Dr. Walkovich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
7th Floor Cs Mott Childrens Hospital
Ann Arbor, MI 48109Phone+1 734-936-9814Fax+1 215-590-2204
Education & Training
- University of MichiganFellowship, Pediatric Hematology/Oncology, 2008 - 2011
- Children's Hospital of PhiladelphiaResidency, Pediatrics, 2005 - 2008
- University of Michigan Medical SchoolClass of 2005
Certifications & Licensure
- MI State Medical License 2008 - 2027
- PA State Medical License 2005 - 2008
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia Start of enrollment: 2013 Jun 01
- Loratadine for Improvement of Bone Pain in Patients With Chronic Granulocyte-Colony Stimulating Factor (G-CSF) Use Start of enrollment: 2019 Jun 24
- Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death Start of enrollment: 2007 Feb 12
Roles: Contact
Publications & Presentations
PubMed
- Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review St...Shanmuganathan Chandrakasan, Carl E Allen, Deepika Bhatla, John Carter, May Chien
Arthritis & Rheumatology. 2024-09-08 - Heterozygous TCF3-related disease presenting as X-linked agammaglobulinemia mimicry in a male toddler with B-cell aplasia, agammaglobulinemia, and severe neutropenia.Laura M Bou-Maroun, Kelly J Walkovich, Lauren Frazier, Mark Hannibal, Thomas F Michniacki
Pediatric Blood & Cancer. 2024-06-01 - 2 citationsReal-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab.Shanmuganathan Chandrakasan, Michael B Jordan, Ashley Baker, Edward M Behrens, Deepika Bhatla
Blood Advances. 2024-05-14
Professional Memberships
- Member
- Member
- Clinical Immunology SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: